| 1 |
Gadepalli A, Akhilesh, Uniyal A, Modi A, Chouhan D, Ummadisetty O, Khanna S, Solanki S, Allani M, Tiwari V. Multifarious Targets and Recent Developments in the Therapeutics for the Management of Bone Cancer Pain. ACS Chem Neurosci 2021;12:4195-208. [PMID: 34723483 DOI: 10.1021/acschemneuro.1c00414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Pierre O, Fouchard M, Le Goux N, Buscaglia P, Leschiera R, Lewis RJ, Mignen O, Fluhr JW, Misery L, Le Garrec R. Pacific-Ciguatoxin-2 and Brevetoxin-1 Induce the Sensitization of Sensory Receptors Mediating Pain and Pruritus in Sensory Neurons. Mar Drugs 2021;19:387. [PMID: 34356812 DOI: 10.3390/md19070387] [Reference Citation Analysis]
|
| 3 |
Sun J, Zhou YQ, Chen SP, Wang XM, Xu BY, Li DY, Tian YK, Ye DW. The endocannabinoid system: Novel targets for treating cancer induced bone pain. Biomed Pharmacother 2019;120:109504. [PMID: 31627091 DOI: 10.1016/j.biopha.2019.109504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Nijs J, Wijma AJ, Leysen L, Pas R, Willaert W, Hoelen W, Ickmans K, Wilgen CPV. Explaining pain following cancer: a practical guide for clinicians. Braz J Phys Ther 2019;23:367-77. [PMID: 30606621 DOI: 10.1016/j.bjpt.2018.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 5 |
Park SH, Eber MR, Widner DB, Shiozawa Y. Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases. Cancers (Basel) 2018;10:E141. [PMID: 29747461 DOI: 10.3390/cancers10050141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 6 |
Zhang M, Gao CX, Wang YP, Ma KT, Li L, Yin JW, Dai ZG, Wang S, Si JQ. The association between the expression of PAR2 and TMEM16A and neuropathic pain. Mol Med Rep 2018;17:3744-50. [PMID: 29257338 DOI: 10.3892/mmr.2017.8295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 7 |
Nijs J, Loggia ML, Polli A, Moens M, Huysmans E, Goudman L, Meeus M, Vanderweeën L, Ickmans K, Clauw D. Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients? Expert Opinion on Therapeutic Targets 2017;21:817-26. [DOI: 10.1080/14728222.2017.1353603] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 8 |
Mrozkova P, Spicarova D, Palecek J. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors. PLoS One 2016;11:e0163991. [PMID: 27755539 DOI: 10.1371/journal.pone.0163991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Mrozkova P, Palecek J, Spicarova D. The role of protease-activated receptor type 2 in nociceptive signaling and pain. Physiol Res 2016;65:357-67. [PMID: 27070742 DOI: 10.33549/physiolres.933269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 10 |
Yau MK, Lim J, Liu L, Fairlie DP. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert Opin Ther Pat 2016;26:471-83. [PMID: 26936077 DOI: 10.1517/13543776.2016.1154540] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 11 |
Frost CØ, Hansen RR, Heegaard AM. Bone pain: current and future treatments. Curr Opin Pharmacol 2016;28:31-7. [PMID: 26940053 DOI: 10.1016/j.coph.2016.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 12 |
Tillu DV, Hassler SN, Burgos-Vega CC, Quinn TL, Sorge RE, Dussor G, Boitano S, Vagner J, Price TJ. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 2015;156:859-67. [PMID: 25734998 DOI: 10.1097/j.pain.0000000000000125] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 13 |
Luo J, Feng J, Liu S, Walters ET, Hu H. Molecular and cellular mechanisms that initiate pain and itch. Cell Mol Life Sci 2015;72:3201-23. [PMID: 25894692 DOI: 10.1007/s00018-015-1904-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 14 |
Bao Y, Hou W, Yang L, Kong X, Du M, Zheng H, Gao Y, Hua B. Protease-Activated Receptor 2 Antagonist Potentiates Analgesic Effects of Systemic Morphine in a Rat Model of Bone Cancer Pain: . Regional Anesthesia and Pain Medicine 2015;40:158-65. [DOI: 10.1097/aap.0000000000000211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 15 |
Hua B, Gao Y, Kong X, Yang L, Hou W, Bao Y. New insights of nociceptor sensitization in bone cancer pain. Expert Opin Ther Targets 2015;19:227-43. [PMID: 25547644 DOI: 10.1517/14728222.2014.980815] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 16 |
Bao Y, Hou W, Yang L, Liu R, Gao Y, Kong X, Shi Z, Li W, Zheng H, Jiang S, Hua B. Increased expression of protease-activated receptor 2 and 4 within dorsal root ganglia in a rat model of bone cancer pain. J Mol Neurosci 2015;55:706-14. [PMID: 25344153 DOI: 10.1007/s12031-014-0409-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 17 |
Bao Y, Hou W, Liu R, Gao Y, Kong X, Yang L, Shi Z, Li W, Zheng H, Jiang S, Li C, Qin Y, Hua B. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain. Mol Pain 2014;10:28. [PMID: 24886294 DOI: 10.1186/1744-8069-10-28] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Bao Y, Hua B, Hou W, Shi Z, Li W, Li C, Chen C, Liu R, Qin Y. Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer. J Mol Neurosci 2014;52:566-76. [PMID: 24057889 DOI: 10.1007/s12031-013-0112-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
